Most investors are on the hunt for stocks that promise fast sales and earnings growth in the years ahead. That makes sense, as companies that can do so for extended periods of time stand a good chance of producing market-beating returns.
With that in mind, I ran a simple screen on Finviz that looked for companies that exhibit two simple criteria.
- Based in the U.S.
- Profitable on a trailing and forward basis.
From there, I simply picked out the three companies with the highest projected EPS growth rate over the coming five years. This methodology produced three stocks -- Incyte Corporation (NASDAQ: INCY) , Covanta Holding (NYSE: CVA) , and Netflix (NASDAQ: NFLX) -- that all promise greater than 50% EPS growth over the long term. Let's take a closer look at each to see if any are worth buying.
A biotech darling
Incyte Corporation is certainly a thriving biotech. The company's crown jewel is a JAK1 and JAK2 inhibitor called Jakafi. This drug treats the bone marrow diseases myelofibrosis and polycythemia vera, both of which are rare. That fact allows Incyte to charge six figures for an annual treatment, which should allow the company's top line to eclipse $1 billion this year.
Beyond Jakafi, Incyte also has a pipeline that is packed with potential. One intriguing product candidate is called epacadostat, which is in late-stage trials as a hopeful treatment for melanoma. If all goes well, it could turn into another home-run drug. Market watchers believe annual sales could eventually eclipse $3 billion if approved.
Investors have since come to embrace the bold decision, and we've seen hit shows like Stranger Things,Narcos, House of Cards, and Orange is the New Black cause membership to skyrocket .
Management believes it will finally have enough scale to drive "material global profits" from 2017 onwards, which sets the company's bottom line up nicely to explode. Market watchers are projecting that EPS will grow by more than 73% annually over the next five years, which makes it the fastest grower on this list.
Are any worth buying?
While you could argue that all three of these companies are deserving of a place in your portfolio, I'm personally the most bullish on Netflix. I've been a longtime investor and customer, and I think the company still has plenty of room left for revenue and profit growth in the years ahead. That's especially true when you consider that the company has only just started to localize its content for international markets. As it starts to crack that nut, international revenue growth should really start to soar. That's why I plan on counting myself as a shareholder for a long time to come.
10 stocks we like better than Netflix
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now...and Netflix wasn't one of them! That's right -- they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of November 7, 2016
Brian Feroldi owns shares of Netflix.Like this article? Follow him on Twitter where he goes by the handle@Longtermmindset or connect with him onLinkedInto see more articles like this.
The Motley Fool owns shares of and recommends Netflix. Try any of our Foolish newsletter services free for 30 days . We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
